scholarly journals Imaging Findings of Lipomatous Hypertrophy of the Interventricular Septum: A Case Report

2021 ◽  
Vol 14 ◽  
pp. 117954762110248
Author(s):  
Selvakumar Subbaraman ◽  
Seena Cheppala Rajan ◽  
Saveetha Veeraiyan ◽  
Paarthipan Natarajan

Primary cardiac tumors are rare. We report a case of lipomatous hypertrophy of the interventricular septum in a healthy, asymptomatic, 16 year old female, diagnosed initially by echocardiogram. Non contrast Computed tomography (CT) and Cardiac magnetic resonance imaging (CMR) were also performed to confirm the diagnosis of this rarely reported condition. Lipomatous hypertrophy of the interventricular septum is a rare form of benign cardiac tumor characterized by the proliferation of adipose tissue (fat) in the interventricular septum. This clinical entity has to be differentiated from cardiac lipoma which is a benign, encapsulated tumor. CMR helps is differentiating between the 2 conditions. As the lesion was neither causing compression of the ventricle nor obstruction to blood flow, she was managed conservatively and advised follow up.

Author(s):  
Rodrigo Maia Alves ◽  
Cristina Gamboa

Cardiac lipomas are rare benign primary neoplasms of the heart, usually found incidentally, that can become symptomatic depending on their size and location. We report the case of a 61-year-old man presenting with chest pain and elevated troponin and a normal EKG and D-dimers. A transthoracic echocardiogram revealed an intracardiac mass attached to the interventricular septum protruding to the left ventricle, later confirmed to be a lipomatous mass consistent with a cardiac lipoma on cardiac magnetic resonance imaging. Due to the mass characteristics and favourable evolution, it was decided not to excise the tumour, and the patient remains asymptomatic after a 4-year follow-up period.


2021 ◽  
Vol 9 (1) ◽  
pp. 84-86
Author(s):  
Pinninti Mounika ◽  
sandhyika B ◽  
Ravinder Reddy Kasturi ◽  
Nikhil Mudgalkar ◽  
Aashish Baviskar

The most common benign cardiac tumor is cardiac myxoma,accounting for around 50% of all primary cardiac tumors. Cardiac myxoma is an uncommon cause ofcardioembolic stroke.Overall,cardioembolic stroke accounts for approximately 30% of all ischemic stroke of which 0.5% of cardioembolic strokes are attributable to a cardiac myxoma.It has an annual incidence of around 0.5 cases per one million people with female predominance. Early diagnosis is necessary to prevent its devastating complications such as embolic stroke and sudden cardiac death.We present a relatively rare case of an acute stroke as a first and only manifestation of an atrial myxoma


2020 ◽  
Vol 54 (1) ◽  
Author(s):  
Dusica Petrovic Rodic

Cardiac tumors are rare (occurring in 0.002-0.3% of autopsies) in all age groups, but they are of clinical relevance due to the affected organ (1). They are classified into primary (benign and malignant) and secondary (metastatic). Myxoma is the most common primary benign cardiac tumor which is usually derived from the multipotent mesenchymal cells of the septum within the left atrium, and due to its localization, it can be considered as "functionally malignant". In autopsy series, it accounts for approximately 50% and in surgical series for up to 80% of all primary cardiac tumors (2). This paper presents a case of cardiac myxoma which is echocardiographically diagnosed in a 34-year-old woman who died suddenly, several days before the scheduled surgery. The diagnosis of the disease was confirmed after the autopsy, by a routine haematoxylin-eosin (H&E) staining method and an additional immunohistochemistry method (IHC). By presenting a rare clinical case, we emphasize the fact that every diagnosed cardiac tumor requires immediate cardiac surgery without delay.   Keywords: cardiac tumors, myxoma, autopsy


2018 ◽  
Vol 07 (01) ◽  
pp. e4-e6
Author(s):  
Georg Schlachtenberger ◽  
Stephen Gerfer ◽  
Axel Kröner ◽  
Thorsten Wahlers

Background Primary cardiac tumors are rare, and many diagnosed tumors are benign with an incidence of 0.001% to 0.03%. The primary angiosarcoma is one of the malignant entities. Discussion We discuss a case report of a 76-year-old male who underwent a preoperative diagnosis for an upcoming shoulder operation when his cardiologist diagnosed a large cardiac tumor. The patient was referred to our department where he received further diagnostics. The transesophageal echocardiography and the cardiac-magnetic resonance imaging showed a massive tumor with a dimension of 8.6 × 5.6 cm with no signs of malignity. Method The operation was performed by standard median sternotomy. The tumor was adherent to the septum and the left atrium, and we were able to remove the specimen in toto. Pathological examinations showed an angiosarcoma with neovascularization and core expression of ERG+ and cytoplasmic expression of CD31+/CD34+, due to the size of the mass. The resection of primary cardiac tumors is mostly the therapy of choice, but in this case concerning an angiosarcoma the prognosis is poor, considering that the angiosarcoma responds very badly to chemotherapy and radiotherapy.


2018 ◽  
Vol 04 (04) ◽  
pp. e176-e181
Author(s):  
Khalil Jawad ◽  
Tamer Owais ◽  
Stefan Feder ◽  
Sven Lehmann ◽  
Martin Misfeld ◽  
...  

Objective The decision to operate cardiac tumors is an issue of balancing surgical outcome and survival with quality of life (QOL). We report our single-center experience in managing primary cardiac tumors between 1994 and 2014. Methods and Results In this study, 269 patients were subjected to our standardized operative protocols, preoperative preparations, postoperative follow-up, and consents of participation. Demographic and preoperative/intraoperative/postoperative variables were collected with focus on long-term follow-up and survival. A total of 72,000 cardiac procedures were performed within 20 years at our institution. Two hundred sixty-nine patients were diagnosed with primary cardiac tumors (0.37%), with a male:female ratio of 1:1.68, mean age of 57.4 ± 19.5 years, and body mass index of 25.49 ± 6.5. The most presenting symptoms were dyspnea (n = 94), arrhythmias (n = 53), embolic event (n = 36), and chest pain (n = 29), and 33 patients were accidentally discovered. Isolated tumor excision and concomitant ablation were performed on 181 patients, while the rest needed additional procedures such as coronary artery bypass grafting (n = 27) or valve surgery (n = 61). Focus on pathology, tumor location was done reporting the commonest pathology such as myxoma (n = 177) and fibroelastoma (n = 56). The frequent site was the left atrium (n = 162). Our primary results showed incidence of bleeding in 9 patients (3.3%), arrhythmias in 76 patients (28.25%), and mortality in 49 patients (18.2%). Five patients (1.8%) showed recurrence and 220 patients (81.8%) showed complaint-free survival. Conclusion Complete excision of primary cardiac tumors is the golden rule in management as it improves survival and decreases morbidity expected from the progressing tumors process. The progression of minimally invasive techniques improves QOL and should be performed whenever possible.


Author(s):  
Du Le Ba Minh

Objective: Prenatal diagnosis, postnatal followed up of three cases of cardiac tumor and successful postnatal surgery of one case. Methods: Treatment and postnatal followed up of three cases of cardiac tumor. Those cases were diagnosed by fetal echocardiography. One of them underwent a successful postnatal surgery. Results: Three fetuses were diagnosed with fetal cardiac tumor (capable of Rhabdomyoma) at 28, 27, 38 gestational weeks. There were many tumors in one or two ventricles. These cases were referred to Hue Central Hospital for timing and location of delivery in 2019. One of them had obstruction of left ventricular outflow tract with successful surgical resection at 46 hours after birth. One of them had heart failure after birth. Evolution of three cases was favorable, heart failure regressed, cardiac tumors regressed at 7 - 9 months follow up. Conclusions: Fetal cardiac tumor can be diagnosed prenatally. Those three cases were capable of rhabdomyoma due to the presence of muliple tumors and their regression after birth. Neonatal surgical option should be reserved for the risk of cardiac flow obstruction.


2013 ◽  
Vol 3 ◽  
pp. 34 ◽  
Author(s):  
Thomas J. Ward ◽  
Michael A. Kadoch ◽  
Adam H. Jacobi ◽  
Pablo P. Lopez ◽  
Javier Sanz Salvo ◽  
...  

The differential diagnosis for a cardiac mass includes primary and metastatic neoplasms. While primary cardiac tumors are rare, metastatic disease to the heart is a common finding in cancer patients. Several “tumor-like” processes can mimic a true cardiac neoplasm with accurate diagnosis critical at guiding appropriate management. We present a pictorial essay of the most common benign cardiac masses and “mass-like” lesions with an emphasis on magnetic resonance imaging features.


1990 ◽  
Vol 119 (5) ◽  
pp. 1215-1217 ◽  
Author(s):  
Haruo Kamiya ◽  
Miyoshi Ohno ◽  
Hirokazu Iwata ◽  
Shigeki Ohsugi ◽  
Ken Sawada ◽  
...  

2021 ◽  
Vol 99 (4) ◽  
pp. 292-294
Author(s):  
V. I. Levin ◽  
V. B. Simonenko ◽  
N. R. Nugaeva ◽  
Z. N. Sukmarova ◽  
O. V. Afonina ◽  
...  

Benign lipomatous formations rank second in frequency among primary cardiac tumors. According to the degree of encapsulation, they are divided into two groups — adipose tumors and lipomatous hypertrophies of interatrial septum. Cases of lipomatosis of the heart and lipomatous hypertrophy of interatrial septum were described in scientifi c editions in years past. Interest in this pathology is related to the question: is it necessary to perform preventive surgical intervention before the appearance of clinical signs of endocardial hemodynamics disturbance? Moreover, the risk associated with surgery is much higher than the existence of a benign hyperplastic process in the anatomical structures of the heart.


Sign in / Sign up

Export Citation Format

Share Document